Clinical Trial: Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia

U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07001865) titled 'Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia' on May 25.

Brief Summary: Although metabolically healthy obesity (MHO) is often considered a relatively benign obesity, its association with the risk of metabolic dysfunction-associated steatotic liver disease (MASLD) and hyperuricemia remains unclear. This study examined the associations between MHO and other metabolic-obesity phenotypes with MASLD and hyperuricemia, and explored the mediating roles of metabolic indicators.This study included 11,712 and 13,846 participants from a health examination cohort at the First Affiliated Hospital of Ningbo Universi...